Not a Portfolio.com Insider?

Subscribe and get a FREE gift!

In This Issue of Condé Nast Portfolio

Home > Resources > Company Profiles > AstraZeneca PLC

AstraZeneca PLC (AZN)

Your Name

Your Email Address *
Send a copy to me

Recipient's Email Address *

Separate multiple email addresses (max 20) with commas.

Subject *

Message

0/1500

Email Confirmation

David R. Brennan , CEO/Director

www.astrazeneca.com

Industry: Healthcare

OPEN

LAST

PREV CLOSE

CHANGE

VOLUME

Overview

News

People

Financials

Overview

A pharmaceutical company, which provides a range of medicines designed to fight disease in important areas of healthcare.

Portfolio Articles

AstraZeneca Scoops up MedImmune
British pharmaceutical giant AstraZeneca pays a premium for MedImmune, banking on its flu and respiratory drugs.

Apr 23 2007

See more news on this company

News Feeds

Pricing, regulation squeezed drug industry in 2008 AP
Dec 31 2008
AstraZeneca says FDA asks for Seroquel detail AP
Dec 24 2008
MAP shares rise on revenue boon from partnership AP
Dec 22 2008
MAP Pharma surges on AstraZeneca development pact AP
Dec 19 2008
Infosys wins deal from AstraZeneca AP
Dec 15 2008
Infinity shares fall as AstraZeneca returns rights AP
Dec 11 2008

Press Releases

MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza Jan-06-2009, 04:42AM EST
Seven Summits Research Releases Comments on HAL, MOS, DOW, AZN, and NSANY Dec-29-2008, 10:15AM EST
AstraZeneca and MAP Pharmaceuticals Announce Worldwide Collaboration to Develop and Commercialize Unit Dose Budesonide Dec-19-2008, 08:04AM EST
AstraZeneca Submits sNDA for NEXIUM(R) for the Short-Term Treatment of GERD in Infants 0 to 1 Year Old Dec-19-2008, 08:00AM EST
SDI and MedImmune Publish Ground-Breaking Study on Geographically Specific, Seasonal RSV Disease Outbreak Data Dec-15-2008, 08:00AM EST

News From Around the Web

News

The state/region in brief (Northwest Arkansas Times)

Jan 09 2009
AP files brief in Neb. cemetery case (Sioux City Journal)

Jan 09 2009
AP Unveils New Media Applications for TV Viewers (Editor & Publisher)

Jan 08 2009
AROUND NY (Albany Times Union)

Jan 08 2009
AP Debuts Microsoft Mediaroom IPTV Concept Applications for TV Viewers (TMCnet.com)

Jan 08 2009
Letters: What in the world? (The Phoenix)

Jan 07 2009
Outlook roundup: Intel, Time Warner (Businessweek)

Jan 07 2009
'Sandy' Colton, former AP photo editor, dies at 83 (ABC 26 New Orleans (WGNO))

Jan 07 2009
Wisconsin briefing (Pioneer Press, Twin Cities, Minnesota)

Jan 07 2009
Wisconsin Badgers football: Getting bombarded with Utah propaganda before final AP vote (Wisconsin State Journal)

Jan 06 2009

Blogs

The Daily Muck (TPM Muckraker)

Jan 08 2009
Best Behavior? (Power Line)

Jan 08 2009
AP: No Experience in new CIA Chief Somehow Shows Obama's 'Clean Break from Bush Administration'? (NewsBusters)

Jan 06 2009

Employees

Number of Employees: 67,900

Revenue per Employee: $428,574

Financials

Quarterly

Annual

Income Statement	09/2008	05/2008	02/2008	11/2007
Sales	994 Mil.	800 Mil.	1.27 Bil.	879 Mil.
Gross Operating Profit	6.96 Bil.	6.88 Bil.	6.9 Bil.	6.27 Bil.
Operating Income before D & A (EBITDA)	2.76 Bil.	2.84 Bil.	2.35 Bil.	2.39 Bil.
Total Income Before Interest Expenses (EBIT)	2.62 Bil.	2.52 Bil.	2.18 Bil.	2.24 Bil.
Total Net Income	1.62 Bil.	1.5 Bil.	1.27 Bil.	1.34 Bil.
Basic EPS, Total	1.11	1.03	0.86	0.91
Diluted EPS, Total	1.11	1.03	0.86	0.9

BALANCE STATEMENT	09/2008	05/2008	02/2008	11/2007
Cash and Equivalents	4.34 Bil.	2.92 Bil.	5.87 Bil.	3.43 Bil.
Total Assets	16.59 Bil.	14.69 Bil.	17.08 Bil.	14.69 Bil.
Total Liabilities	15.99 Bil.	15.68 Bil.	15.19 Bil.	15.53 Bil.
Total Capitalization	27.01 Bil.	25.84 Bil.	26.03 Bil.	23.61 Bil.

Cash Flow	09/2008	05/2008	02/2008	11/2007
Net Cash From Continuing Operations	4.29 Bil.	2.39 Bil.	7.51 Bil.	4.51 Bil.
Net Cash From Investing Activities	-3.2 Bil.	-2.94 Bil.	-14.89 Bil.	-14.46 Bil.
Net Cash From Financing Activities	-2.55 Bil.	-2.38 Bil.	6.05 Bil.	6.25 Bil.
Net Change in Cash & Cash Equivalents	-1.46 Bil.	-2.93 Bil.	-1.26 Bil.	-3.64 Bil.

Income Statement	2008	2007	2006	2005
Sales	4.56 Bil.	4.21 Bil.	4.03 Bil.	3.88 Bil.
Gross Operating Profit	25 Bil.	22.26 Bil.	19.92 Bil.	17.54 Bil.
Operating Income before D & A (EBITDA)	9.22 Bil.	9.04 Bil.	7.64 Bil.	5.72 Bil.
Total Income Before Interest Expenses (EBIT)	9.05 Bil.	9.09 Bil.	7.17 Bil.	4.91 Bil.
Total Net Income	5.6 Bil.	6.04 Bil.	4.71 Bil.	3.81 Bil.
Basic EPS, Total	3.74	3.86	2.91	2.28
Diluted EPS, Total	3.73	3.85	2.91	2.28

BALANCE STATEMENT	2008	2007	2006	2005
Cash and Equivalents	5.87 Bil.	7.1 Bil.	545 Mil.	1.06 Bil.
Total Assets	17.08 Bil.	16.94 Bil.	13.77 Bil.	14.44 Bil.
Total Liabilities	15.19 Bil.	9.45 Bil.	6.84 Bil.	7.78 Bil.
Total Capitalization	26.03 Bil.	16.39 Bil.	14.71 Bil.	15.45 Bil.

Cash Flow	2008	2007	2006	2005
Net Cash From Continuing Operations	7.51 Bil.	7.69 Bil.	6.74 Bil.	4.87 Bil.
Net Cash From Investing Activities	-14.89 Bil.	-272 Mil.	-1.18 Bil.	-941 Mil.
Net Cash From Financing Activities	6.05 Bil.	-5.37 Bil.	-4.57 Bil.	-3.62 Bil.
Net Change in Cash & Cash Equivalents	-1.26 Bil.	2.09 Bil.	968 Mil.	309 Mil.